1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow EPI-506: new trials by email Literature Review of EPI-506 trials Research Report on EPI-506
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer EPI-506 - Prostatic Neoplasms, Genital Neoplasms, Male | Phase 1 / Phase 2 | Terminated | ESSA Pharmaceuticals | 28 | 2015-10-01 | 2018-03-01 |
Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Prostatic Diseases (1) · Prostatic Neoplasms (1)
Canada (1) · United States (1)
Frank Perabo, MD, PhD (1) · Kim N. Chi, MD (1) · Robert B. Montgomery, MD (1)